SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-002727
Filing Date
2021-11-03
Accepted
2021-11-03 07:18:21
Documents
13
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20211103.htm   iXBRL 8-K 54917
2 EX-99.1 oncr-ex99_1.htm EX-99.1 182980
  Complete submission text file 0000950170-21-002727.txt   371461

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20211103_lab.xml EX-101.LAB 13896
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20211103_pre.xml EX-101.PRE 10220
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20211103.xsd EX-101.SCH 2472
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20211103_htm.xml XML 4880
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 211373714
SIC: 2834 Pharmaceutical Preparations